Liminatus Pharma Statistics
Total Valuation
LIMN has a market cap or net worth of $3.95 million. The enterprise value is $2.37 million.
| Market Cap | 3.95M |
| Enterprise Value | 2.37M |
Important Dates
The next estimated earnings date is Monday, November 23, 2026, before market open.
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LIMN has 1.34 million shares outstanding. The number of shares has increased by 82.95% in one year.
| Current Share Class | 1.34M |
| Shares Outstanding | 1.34M |
| Shares Change (YoY) | +82.95% |
| Shares Change (QoQ) | +34.44% |
| Owned by Insiders (%) | 12.21% |
| Owned by Institutions (%) | 10.37% |
| Float | 1.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.95 |
| P/TBV Ratio | 13.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 4.80.
| Current Ratio | 1.12 |
| Quick Ratio | 0.99 |
| Debt / Equity | 4.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -95.65% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1,119.03% |
| Weighted Average Cost of Capital (WACC) | 7.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$12.52M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.06% in the last 52 weeks. The beta is 0.78, so LIMN's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -95.06% |
| 50-Day Moving Average | 3.39 |
| 200-Day Moving Average | 9.73 |
| Relative Strength Index (RSI) | 46.23 |
| Average Volume (20 Days) | 32,303 |
Short Selling Information
The latest short interest is 39,632, so 2.95% of the outstanding shares have been sold short.
| Short Interest | 39,632 |
| Short Previous Month | 44,566 |
| Short % of Shares Out | 2.95% |
| Short % of Float | 3.87% |
| Short Ratio (days to cover) | 1.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.07M |
| Pretax Income | -12.52M |
| Net Income | -12.52M |
| EBITDA | -4.06M |
| EBIT | -4.07M |
| Earnings Per Share (EPS) | -$18.06 |
Balance Sheet
The company has $3.02 million in cash and $1.44 million in debt, with a net cash position of $1.57 million or $1.17 per share.
| Cash & Cash Equivalents | 3.02M |
| Total Debt | 1.44M |
| Net Cash | 1.57M |
| Net Cash Per Share | $1.17 |
| Equity (Book Value) | 300,612 |
| Book Value Per Share | 0.27 |
| Working Capital | 352,044 |
Cash Flow
In the last 12 months, operating cash flow was -$3.97 million and capital expenditures -$13,108, giving a free cash flow of -$3.99 million.
| Operating Cash Flow | -3.97M |
| Capital Expenditures | -13,108 |
| Depreciation & Amortization | 2,071 |
| Net Borrowing | -1.30M |
| Free Cash Flow | -3.99M |
| FCF Per Share | -$2.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LIMN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -82.95% |
| Shareholder Yield | -82.95% |
| Earnings Yield | -614.31% |
| FCF Yield | -100.93% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 21, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | Aug 21, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |